Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christopher Rieken
PHIP as a Therapeutic Target for Driver-Negative Subtypes of Melanoma, Breast, and Lung Cancer
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
ICAM-1 as a Molecular Target for Triple Negative Breast Cancer
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple Negative Breast Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Neuropilin-1 as Therapeutic Target for Malignant Melanoma
Frontiers in Oncology
Cancer Research
Oncology
Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer
Genes and Cancer
Cancer Research
Genetics
O1-19-1Characterization of URST1 as a Biomarker and Therapeutic Target for Lung Cancer and Oral Cancer
Annals of Oncology
Medicine
Oncology
Hematology
TIMP-3 as a Therapeutic Target for Cancer
Therapeutic Advances in Medical Oncology
Oncology
Molecular Stratification Within Triple-Negative Breast Cancer Subtypes
Scientific Reports
Multidisciplinary
Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
PLoS ONE
Multidisciplinary